People receiving talking therapy for mild to severe depression reported greater improvements to their symptoms when also taking creatine compared with those on a placebo ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
Using computational models, the researchers studied how the brain's reward-learning system functions in those with depression, especially among individuals experiencing anhedonia, the inability to ...
And a large-scale study Professor Jacka co-authored last year showed Mediterranean diets may prevent depression as well as treat it. Data from 3,000 adults showed that, after six years ...
New research highlights how the brain's reward-learning system can guide personalized treatments for depression.
The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...